Key facts
- This page summarizes Patrick Taylor Horn's Form 4 filing for Fulcrum Therapeutics, Inc. (FULC).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 20 Mar 2024, 16:15.
Patrick Taylor Horn - 18 Mar 2024 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- FULC
- Reported as of
- 18 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Mar 2024, 16:15:10 UTC
- Prior SEC filing
- 25 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Greg Tourangeau as attorney-in-fact for Patrick Horn
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Patrick Taylor Horn filed Form 4 for Fulcrum Therapeutics, Inc. (FULC) on 20 Mar 2024.
Change
- Previous filing in this sequence was filed on 25 Oct 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FULC
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +400,000
- Change %
- Price
- $0.000000
- Shares after
- 400,000
- Date
- 18 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 400,000
- Exercise price
- $10.12
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This option was granted on March 18, 2024 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of March 18, 2024. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.